Economic evaluation of interventions for inflammatory rheumatic diseases
- Prosjektnummer
- 2010106
- Ansvarlig person
- Tore Kristian Kvien
- Institusjon
- Diakonhjemmet Sykehus AS
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Inflammatory and Immune System
- Forskningsaktivitet
- 8. Health Services
Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
Rheumatology (Oxford) 2015 Jul;54(7):1226-35. Epub 2015 jan 7
PMID: 25573840 - Inngår i doktorgradsavhandlingen
Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry.
Rheumatology (Oxford) 2012 Sep;51(9):1618-27. Epub 2012 apr 25
PMID: 22539479 - Inngår i doktorgradsavhandlingen
Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies.
Scand J Rheumatol 2011 Mar;40(2):108-15. Epub 2011 jan 17
PMID: 21241197
Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
J Rheumatol 2010 Jan;37(1):26-31. Epub 2009 des 1
PMID: 19955045 - Inngår i doktorgradsavhandlingen
Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life
Rheumatology (Oxford) 2012 Sep;51(9):1618-27. Epub 2012 apr 25 PMID: 22539479
Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes
J Rheumatol 2010 Jan;37(1):26-31. Epub 2009 des 1 PMID: 19955045
Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies.
Scand J Rheumatol 2011 Mar;40(2):108-15. Epub 2011 jan 17, PMID: 21241197
Hva koster det å behandle en pasient, og hva koster det å la være?
Revmatikeren 5:2012
Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis..
Rheumatology 2015; doi: 10.1093/rheumatology/keu460
Hva koster det å behandle en pasient, og hva koster det å la være?
Revmatikeren 5:12
Economic evaluation of interventions for inflammatory rheumatic joint diseases
- Disputert:
- april 2015
- Hovedveileder:
- Ivar Sønbø Kristiansen
- Elisabeth Lie Postdoktorstipendiat
- Tillmann Uhlig Forsker (annen finansiering)
- Tron Anders Moger Forsker (annen finansiering)
- Ivar Sønbø Kristiansen Hovedveileder
- Tore Kristian Kvien Medveileder
- Maria Knoph Kvamme Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport